Equipoise Injectable 50 mg Solution is a Health Canada–registered veterinary drug (DIN 02223619) held by Wyeth Animal Health, Division Of Wyeth Canada, containing Boldenone Undecylenate. Health Canada lists its status as Cancelled Post Market (status date 21 Jul 2011). Nexara Health has matched 1 registration of Boldenone Undecylenate across 1 other regulated market.
Health Canada registration
| DIN | 02223619 |
|---|---|
| Brand name | Equipoise Injectable |
| Active ingredient | Boldenone Undecylenate |
| Strength | 50 mg |
| Dosage form | Solution |
| Route | Intramuscular |
| Company | Wyeth Animal Health, Division Of Wyeth Canada |
| Status | Cancelled Post Market — 21 Jul 2011 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Boldenone Undecylenate registered in other markets
1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Boldenone Undecylenate | Steroid SpA | Liquid | FDA NDC |
See every manufacturer of Boldenone Undecylenate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Equipoise Injectable (DIN 02223619) marketed in Canada?
No. Health Canada lists DIN 02223619 as Cancelled Post Market as of 21 Jul 2011.
Who holds the Canadian licence for this product?
Wyeth Animal Health, Division Of Wyeth Canada is the company of record in the Health Canada Drug Product Database.
Is Boldenone Undecylenate registered outside Canada?
Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02223619, status date 2011-07-21; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02223619, status date 2011-07-21; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02223619, status date 2011-07-21; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.